Pharmagen, Inc.
PHRXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$5171
P/E Ratio—
52W High$0.00001
52W Low$0.000001
Pharmagen, Inc.（PHRX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PHRX · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2013-12 |
|---|---|
| Revenue | |
| Revenue | $0.00M |
| Cost of Revenue | $0.00M |
| Gross Profit | $0.00M |
| Gross Margin %(computed) | 63.27% |
| Operating Expenses | |
| R&D Expenses | $0.00M |
| G&A Expenses | $0.00M |
| Total Operating Expenses | $0.01M |
| Operating Income | ($0.00M) |
| Operating Margin %(computed) | -44.86% |
| Interest Income | $0.00M |
| Interest Expense | $3.01M |
| Income Before Tax | ($0.01M) |
| Income Tax Expense | $0.00M |
| Net Income | ($0.01M) |
| Net Margin %(computed) | -134.17% |
| Per Share & EBITDA | |
| EPS (Basic) | $-0.02 |
| Wtd Avg Shares | 0.38M |
| EBITDA | ($2.89M) |
| EBITDA Margin %(computed) | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Pharmagen, Inc.
关于Pharmagen, Inc.（PHRX）损益表
Pharmagen, Inc.（PHRX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2013财年，PHRX实现营收$0.00B，毛利润$0.00B（毛利率63.27%），净利润($0.00B)（净利率-134.17%）。
常见问题
PHRX · 4 问Pharmagen, Inc.（PHRX）2013财年营收为$0.00B，同比down—%。
PHRX revenuePHRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09